TIAA CREF Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $3.11M | Sell |
32,544
-444
| -1% | -$42.4K | ﹤0.01% | 1744 |
|
2018
Q4 | $2.34M | Sell |
32,988
-1,466
| -4% | -$104K | ﹤0.01% | 1862 |
|
2018
Q3 | $2.94M | Sell |
34,454
-2,806
| -8% | -$240K | ﹤0.01% | 1928 |
|
2018
Q2 | $4.32M | Sell |
37,260
-1,457
| -4% | -$169K | ﹤0.01% | 1709 |
|
2018
Q1 | $3.13M | Buy |
38,717
+476
| +1% | +$38.5K | ﹤0.01% | 1853 |
|
2017
Q4 | $2.24M | Sell |
38,241
-2,843
| -7% | -$167K | ﹤0.01% | 2074 |
|
2017
Q3 | $1.92M | Sell |
41,084
-1,867
| -4% | -$87.4K | ﹤0.01% | 2189 |
|
2017
Q2 | $1.55M | Sell |
42,951
-382
| -0.9% | -$13.7K | ﹤0.01% | 2337 |
|
2017
Q1 | $1.34M | Sell |
43,333
-4,258
| -9% | -$131K | ﹤0.01% | 2366 |
|
2016
Q4 | $1.59M | Sell |
47,591
-15,724
| -25% | -$527K | ﹤0.01% | 2309 |
|
2016
Q3 | $1.69K | Sell |
63,315
-26,309
| -29% | -$700 | ﹤0.01% | 2264 |
|
2016
Q2 | $1.98M | Buy |
89,624
+776
| +0.9% | +$17.1K | ﹤0.01% | 2134 |
|
2016
Q1 | $2.61M | Buy |
88,848
+30,840
| +53% | +$906K | ﹤0.01% | 1928 |
|
2015
Q4 | $1.92M | Sell |
58,008
-9,589
| -14% | -$317K | ﹤0.01% | 2183 |
|
2015
Q3 | $2.44M | Sell |
67,597
-1,399
| -2% | -$50.6K | ﹤0.01% | 2024 |
|
2015
Q2 | $3.1M | Buy |
68,996
+10,905
| +19% | +$491K | ﹤0.01% | 2016 |
|
2015
Q1 | $1.78M | Sell |
58,091
-788
| -1% | -$24.1K | ﹤0.01% | 2290 |
|
2014
Q4 | $2.99M | Sell |
58,879
-1,006
| -2% | -$51.2K | ﹤0.01% | 1977 |
|
2014
Q3 | $2.37M | Sell |
59,885
-14,877
| -20% | -$589K | ﹤0.01% | 2116 |
|
2014
Q2 | $3.22M | Buy |
74,762
+2,216
| +3% | +$95.4K | ﹤0.01% | 1998 |
|
2014
Q1 | $2.9M | Buy |
72,546
+36,976
| +104% | +$1.48M | ﹤0.01% | 2013 |
|
2013
Q4 | $970K | Buy |
35,570
+20,755
| +140% | +$566K | ﹤0.01% | 2692 |
|
2013
Q3 | $340K | Buy |
14,815
+463
| +3% | +$10.6K | ﹤0.01% | 3015 |
|
2013
Q2 | $254K | Buy |
+14,352
| New | +$254K | ﹤0.01% | 3035 |
|